Cymbiotika has a winning formula.
What’s happening: The premium supplements brand raised $25M in funding, adding notable investors across sports and music industries.
Big squeeze. Crafting clinically tested supplements in liquid and liposomal gel form, Cymbiotika emphasizes bioavailable formulas better metabolized by the human body than pills or powder.
From Irish sea moss to magnesium complex, its single-serve packets create daily rituals for cognitive performance, energy, beauty, and more. Selling 100M+ to date, a new distribution deal with Target puts the brand on track for $150M+ in 2025 sales.
Poppin’. Along with ingredient transparency and precision dosing, consumers are seeking out novel form factors that merge functional with practical.
From GRÜNS and Create to Kourtney Kardashian’s Lemme, the great gummy-fication of wellness supplements spans greens, creatine, and colostrum — while Momentous is exploring gelatin-free chews.
Formulating East-meets-West tinctures for beauty and metabolism, Apothékary just entered Ulta and Whole Foods, while women’s telehealth platform Wisp is working on peptide patches and topicals for longevity.
A go-to for elite performers, Maurten’s sports hydrogel fueled NYC Marathon record-setter Hellen Obiri to victory. A complement, amplifye’s novel enzyme maximizes protein absorption.
Punchline: Already massive, the supplements industry is surging to even greater heights on novel, stackable form factors with broad benefits.
